viobright fitc anti cd8a (Miltenyi Biotec)

Miltenyi Biotec is a verified supplier

Miltenyi Biotec manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Miltenyi Biotec viobright fitc anti cd8a
Viobright Fitc Anti Cd8a, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 106 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd8a+viobright+fitc/CD8a+Antibody%2C+anti-mouse%2C+REAfinity/pm41932901-244-19-24
Average 94 stars, based on 106 article reviews

viobright fitc anti cd8a - by Bioz Stars, 2026-10

94/100 stars

Images

other:

Article Title: Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Article Snippet: Panels for EO771 Tumors: CD8± T, NK and NKT cell panel: CD45PerCP-Vio770 (Miltenyi Biotec, Cat.# 130-110-663, mouse, clone: REA737, 1:50 dilution), CD3-APC-Vio770 (Miltenyi Biotec, Cat.# 130-119-793, mouse, clone: REA641, 1:50 dilution), CD8a-VioBright FITC (Miltenyi Biotec, Cat.# 130-120-822, mouse, clone: REA601, 1:50 dilution), CD107b-AlexaFluor647 (BioLegend, Cat.# 108 512, mouse, clone: M3/84, 2.5 μg mL−1), CD279 (PD1)-PE (Miltenyi Biotec, Cat.# 130-111-953, mouse, clone: REA802, 1:50 dilution), anti-NK1.1(CD161)-PE-Vio770 (Miltenyi Biotec, Cat.# 130-120-509, mouse, clone: REA1162, 1:50 dilution), IL2-Brilliant Violet 711 (BioLegend, Cat.# 503 837, mouse, clone: JES6-5H4, 5 μg mL−1), Anti-IFN-ɣ -Brilliant Violet 785 (BioLegend, Cat.# 505 838, mouse, clone: XMG1.2, 2.5 μg mL−1), Anti-TNF-α-Brilliant Violet 421 (BioLegend, Cat.# 506 328, mouse, clone: MP6-XT22, 2.5 μg mL−1).

Article Title: Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Article Snippet: CD8 ± T, NK and NKT cell panel : CD45‐PerCP‐Vio770 (Miltenyi Biotec, Cat.# 130‐110‐663, mouse, clone: REA737, 1:50 dilution), CD3‐APC‐Vio770 (Miltenyi Biotec, Cat.# 130‐119‐793, mouse, clone: REA641, 1:50 dilution), CD8a‐VioBright FITC (Miltenyi Biotec, Cat.# 130‐120‐822, mouse, clone: REA601, 1:50 dilution), CD107b‐AlexaFluor647 (BioLegend, Cat.# 108 512, mouse, clone: M3/84, 2.5 μg mL −1 ), CD279 (PD1)‐PE (Miltenyi Biotec, Cat.# 130‐111‐953, mouse, clone: REA802, 1:50 dilution), anti‐NK1.1(CD161)‐PE‐Vio770 (Miltenyi Biotec, Cat.# 130‐120‐509, mouse, clone: REA1162, 1:50 dilution), IL‐2‐Brilliant Violet 711 (BioLegend, Cat.# 503 837, mouse, clone: JES6‐5H4, 5 μg mL −1 ), Anti‐IFN‐ɣ ‐Brilliant Violet 785 (BioLegend, Cat.# 505 838, mouse, clone: XMG1.2, 2.5 μg mL −1 ), Anti‐TNF‐α‐Brilliant Violet 421 (BioLegend, Cat.# 506 328, mouse, clone: MP6‐XT22, 2.5 μg mL −1 ).

Biomarker Discovery:

Article Title: Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens
Article Snippet: .. Annexin V-PE (Biolegend; cat 640947; lot B260064); PE anti mouse H-2Kb (Biolegend; cat 116508, clone AF6-885; lot B238421); PerCp Cy5.5 anti mouse H-2Kb (Biolegend, cat116516; clone AF688.5); CD8a VioBright FITC (Miltenyi; 130-109-477; REA601; lot 5190924578); OVA dextramer (Immudex; JD2163; RUO; lot 20190429-EA18) Describe the validation of each primary antibody for the species and application, noting any validation statements on the manufacturer’s website, relevant citations, antibody profiles in online databases, or data provided in the manuscript. .. MCA205 were purchase from Merck and B16F10 from ATCC The cell lines were authenticated by Merck and ATCC All cell lines were tested for mycoplasma contamination and data are shown for mycoplasma-free cells Name any commonly misidentified cell lines used in the study and provide a rationale for their use.

Review

viobright fitc anti cd8a (Miltenyi Biotec)

Structured Review

Images

Related Articles

other:

Biomarker Discovery:

Similar Products

Image Search Results